We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ahead of Elevance Health (ELV) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Elevance Health (ELV - Free Report) will report quarterly earnings of $11.09 per share in its upcoming release, pointing to a year-over-year increase of 4.2%. It is anticipated that revenues will amount to $45.93 billion, exhibiting an increase of 8.7% compared to the year-ago quarter.
The current level reflects a downward revision of 1.5% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
With that in mind, let's delve into the average projections of some Elevance Health metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts expect 'Revenues- Premiums' to come in at $38.66 billion. The estimate indicates a year-over-year change of +8.3%.
The combined assessment of analysts suggests that 'Revenues- Service fees' will likely reach $2.13 billion. The estimate points to a change of +2.6% from the year-ago quarter.
Analysts predict that the 'Revenues- Net investment income' will reach $461.32 million. The estimate indicates a year-over-year change of -0.8%.
Analysts' assessment points toward 'Revenues- Product revenue' reaching $5.11 billion. The estimate indicates a change of +13.6% from the prior-year quarter.
Analysts forecast 'Total Medical Membership' to reach 46.24 million. Compared to the present estimate, the company reported 46.24 million in the same quarter last year.
The consensus among analysts is that 'Medical Membership - Medicare - Medicare Advantage' will reach 2.21 million. Compared to the present estimate, the company reported 2.02 million in the same quarter last year.
The collective assessment of analysts points to an estimated 'Medical Membership - Medicaid' of 8.89 million. Compared to the current estimate, the company reported 9.33 million in the same quarter of the previous year.
The average prediction of analysts places 'Medical Membership - Federal Employees Health Benefits' at 1.66 million. The estimate compares to the year-ago value of 1.66 million.
The consensus estimate for 'Medical Membership - Total Medicare' stands at 3.08 million. The estimate compares to the year-ago value of 2.91 million.
It is projected by analysts that the 'Medical Membership - Commercial Risk-Based - Individual' will reach 1.42 million. Compared to the current estimate, the company reported 1.25 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Benefit Expense Ratio' should arrive at 87.3%. Compared to the current estimate, the company reported 85.6% in the same quarter of the previous year.
According to the collective judgment of analysts, 'Medical Membership - Commercial Fee-Based' should come in at 27.44 million. The estimate is in contrast to the year-ago figure of 27.45 million.
Elevance Health shares have witnessed a change of +0.4% in the past month, in contrast to the Zacks S&P 500 composite's -4.2% move. With a Zacks Rank #3 (Hold), ELV is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Ahead of Elevance Health (ELV) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Elevance Health (ELV - Free Report) will report quarterly earnings of $11.09 per share in its upcoming release, pointing to a year-over-year increase of 4.2%. It is anticipated that revenues will amount to $45.93 billion, exhibiting an increase of 8.7% compared to the year-ago quarter.
The current level reflects a downward revision of 1.5% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
With that in mind, let's delve into the average projections of some Elevance Health metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts expect 'Revenues- Premiums' to come in at $38.66 billion. The estimate indicates a year-over-year change of +8.3%.
The combined assessment of analysts suggests that 'Revenues- Service fees' will likely reach $2.13 billion. The estimate points to a change of +2.6% from the year-ago quarter.
Analysts predict that the 'Revenues- Net investment income' will reach $461.32 million. The estimate indicates a year-over-year change of -0.8%.
Analysts' assessment points toward 'Revenues- Product revenue' reaching $5.11 billion. The estimate indicates a change of +13.6% from the prior-year quarter.
Analysts forecast 'Total Medical Membership' to reach 46.24 million. Compared to the present estimate, the company reported 46.24 million in the same quarter last year.
The consensus among analysts is that 'Medical Membership - Medicare - Medicare Advantage' will reach 2.21 million. Compared to the present estimate, the company reported 2.02 million in the same quarter last year.
The collective assessment of analysts points to an estimated 'Medical Membership - Medicaid' of 8.89 million. Compared to the current estimate, the company reported 9.33 million in the same quarter of the previous year.
The average prediction of analysts places 'Medical Membership - Federal Employees Health Benefits' at 1.66 million. The estimate compares to the year-ago value of 1.66 million.
The consensus estimate for 'Medical Membership - Total Medicare' stands at 3.08 million. The estimate compares to the year-ago value of 2.91 million.
It is projected by analysts that the 'Medical Membership - Commercial Risk-Based - Individual' will reach 1.42 million. Compared to the current estimate, the company reported 1.25 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Benefit Expense Ratio' should arrive at 87.3%. Compared to the current estimate, the company reported 85.6% in the same quarter of the previous year.
According to the collective judgment of analysts, 'Medical Membership - Commercial Fee-Based' should come in at 27.44 million. The estimate is in contrast to the year-ago figure of 27.45 million.
View all Key Company Metrics for Elevance Health here>>>
Elevance Health shares have witnessed a change of +0.4% in the past month, in contrast to the Zacks S&P 500 composite's -4.2% move. With a Zacks Rank #3 (Hold), ELV is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>